|
| 36516964 | The PrU: Development and validation of a measure to assess personal utility of genomic results. | Genet Med | 2023 |
| 37644850 | Risk management actions following genetic testing in the Cancer Health Assessments Reaching Many (CHARM) Study: A prospective cohort study. | Cancer Med | 2023 |
| 37126135 | Evaluating cancer genetic services in a safety net system: overcoming barriers for a lasting impact beyond the CHARM research project. | J Community Genet | 2023 |
| 37421176 | Most people share genetic test results with relatives even if the findings are normal: Family communication in a diverse population. | Genet Med | 2023 |
| 37470892 | Longitudinal adherence to breast cancer surveillance following cancer genetic testing in an integrated health care system. | Breast Cancer Res Treat | 2023 |
| 34302314 | Barriers to family history knowledge and family communication among LGBTQ+ individuals in the context of hereditary cancer risk assessment. | J Genet Couns | 2022 |
| 35679147 | Risk-reducing surgery in unaffected individuals receiving cancer genetic testing in an integrated health care system. | Cancer | 2022 |
| 35348718 | Developing an algorithm across integrated healthcare systems to identify a history of cancer using electronic medical records. | J Am Med Inform Assoc | 2022 |
| 35436948 | Identifying patients with Lynch syndrome using a universal tumor screening program in an integrated healthcare system. | Hered Cancer Clin Pract | 2022 |
| 35341655 | ClinGen's Pediatric Actionability Working Group: Clinical actionability of secondary findings from genome-scale sequencing in children and adolescents. | Genet Med | 2022 |
| 35363504 | Establishing the Medical Actionability of Genomic Variants. | Annu Rev Genomics Hum Genet | 2022 |
| 35689290 | Literacy-adapted, electronic family history assessment for genetics referral in primary care: patient user insights from qualitative interviews. | Hered Cancer Clin Pract | 2022 |
| 35522237 | ORCA, a values-based decision aid for selecting additional findings from genomic sequencing in adults: Efficacy results from a randomized trial. | Genet Med | 2022 |
| 35933674 | Engaging Patient Advisory Committees to Inform a Genomic Cancer Risk Study: Lessons for Future Efforts. | Perm J | 2022 |
| 36053287 | An accessible, relational, inclusive, and actionable (ARIA) model of genetic counseling compared with usual care: Results of a randomized controlled trial. | Genet Med | 2022 |
| 33754278 | Adaptation and early implementation of the PREdiction model for gene mutations (PREMM<sub>5</sub>â¿¢) for lynch syndrome risk assessment in a diverse population. | Fam Cancer | 2022 |
| 35123916 | Corrigendum to "Cancer Health Assessments Reaching Many (CHARM): A clinical trial assessing a multimodal cancer genetics services delivery program and its impact on diverse populations" [Contemporary Clinical Trials 106 (2021) 106432]. | Contemp Clin Trials | 2022 |
| 34906471 | Motivations and concerns of patients considering participation in an implementation study of a hereditary cancer risk assessment program in diverse primary care settings. | Genet Med | 2022 |
| 35144679 | Retrospective assessment of barriers and access to genetic services for hereditary cancer syndromes in an integrated health care delivery system. | Hered Cancer Clin Pract | 2022 |
| 32981477 | Participant Reactions to a Literacy-Focused, Web-Based Informed Consent Approach for a Genomic Implementation Study. | AJOB Empir Bioeth | 2021 |
| 33549385 | Development and early implementation of an Accessible, Relational, Inclusive and Actionable approach to genetic counseling: The ARIA model. | Patient Educ Couns | 2021 |
| 34460173 | Impact of expanded carrier screening on health care utilization. | Am J Manag Care | 2021 |
| 34778694 | Systemic Barriers to Risk-Reducing Interventions for Hereditary Cancer Syndromes: Implications for Health Care Inequities. | JCO Precis Oncol | 2021 |
| 33984519 | Cancer Health Assessments Reaching Many (CHARM): A clinical trial assessing a multimodal cancer genetics services delivery program and its impact on diverse populations. | Contemp Clin Trials | 2021 |
| 33191058 | A decision aid for additional findings in genomic sequencing: Development and pilot testing. | Patient Educ Couns | 2021 |
| 32125936 | Assessing the implications of positive genomic screening results. | Per Med | 2020 |
| 33948230 | Lessons learned about harmonizing survey measures for the CSER consortium. | J Clin Transl Sci | 2020 |
| 32089547 | Integrating stakeholder feedback in translational genomics research: an ethnographic analysis of a study protocol's evolution. | Genet Med | 2020 |
| 33416699 | Discordant Patient and Clinician Perspectives on the Potential Value of Genetic Services in Safety-Net Clinics. | J Health Care Poor Underserved | 2020 |
| 33023975 | Demonstrating 'respect for persons' in clinical research: findings from qualitative interviews with diverse genomics research participants. | J Med Ethics | 2020 |
| 30670880 | Correction: Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study. | Genet Med | 2019 |
| 32025627 | Cost-Effectiveness of Risk-Stratified Colorectal Cancer Screening Based on Polygenic Risk: Current Status and Future Potential. | JNCI Cancer Spectr | 2019 |
| 31890059 | Recommended care and care adherence following a diagnosis of Lynch syndrome: a mixed-methods study. | Hered Cancer Clin Pract | 2019 |
| 29875426 | Returning negative results to individuals in a genomic screening program: lessons learned. | Genet Med | 2019 |
| 30245516 | The evolving landscape of expanded carrier screening: challenges and opportunities. | Genet Med | 2019 |
| 30729418 | Implementation of a Systematic Tumor Screening Program for Lynch Syndrome in an Integrated Health Care Setting. | Fam Cancer | 2019 |
| 31028355 | Expert and lay perspectives on burden, risk, tolerability, and acceptability of clinical interventions for genetic disorders. | Genet Med | 2019 |
| 31104772 | The Genomic Medicine Integrative Research Framework: A Conceptual Framework for Conducting Genomic Medicine Research. | Am J Hum Genet | 2019 |
| 30287922 | Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study. | Genet Med | 2019 |
| 29293279 | Patient actions and reactions after receiving negative results from expanded carrier screening. | Clin Genet | 2018 |
| 30193136 | The Clinical Sequencing Evidence-Generating Research Consortium: Integrating Genomic Sequencing in Diverse and Medically Underserved Populations. | Am J Hum Genet | 2018 |
| 30133189 | Approaches to carrier testing and results disclosure in translational genomics research: The clinical sequencing exploratory research consortium experience. | Mol Genet Genomic Med | 2018 |
| 30020962 | Assessment of willingness to pay for expanded carrier screening among women and couples undergoing preconception carrier screening. | PLoS One | 2018 |
| 30455898 | A case for expanding carrier testing to include actionable X-linked disorders. | Clin Case Rep | 2018 |
| 30311382 | Evidence-based assessments of clinical actionability in the context of secondary findings: Updates from ClinGen's Actionability Working Group. | Hum Mutat | 2018 |
| 29423569 | Time Costs for Genetic Counseling in Preconception Carrier Screening with Genome Sequencing. | J Genet Couns | 2018 |
| 29754767 | Preconception Carrier Screening by Genome Sequencing: Results from the Clinical Laboratory. | Am J Hum Genet | 2018 |
| 29388940 | Anticipated responses of early adopter genetic specialists and nongenetic specialists to unsolicited genomic secondary findings. | Genet Med | 2018 |
| 29760830 | Patient and provider perspectives on adherence to and care coordination of lynch syndrome surveillance recommendations: findings from qualitative interviews. | Hered Cancer Clin Pract | 2018 |
| 29733724 | Lessons Learned From A Study Of Genomics-Based Carrier Screening For Reproductive Decision Making. | Health Aff (Millwood) | 2018 |